News
Why CRISPR-Cas SDN-1 is relevant to the UPSC exam? What is the significance of topics such as Sixteenth Finance Commission, ...
The biotech has nominated MB-111, a drug it's developing as a treatment for elevated triglycerides, as its first clinical development candidate.
Glioblastoma may be driven by 3D DNA folding patterns, not just mutations, offering new paths for treatment. A new ...
University of Pennsylvania researchers have developed a powerful new investigative tool to reveal how proteins work inside ...
Liquidia Technologies (LQDA) witnessed a jump in share price last session on above-average trading volume. The latest trend ...
From STAT’s Adam Feuerstein: The FDA informed Capricor Therapeutics that a meeting of outside experts will be convened to ...
Pikes Peak State College students are benefitting from a new $1.5 million grant. It’ll give them first-hand experience with ...
Developed at the Children's Hospital of Philadelphia (CHOP) and called Zynteglo, the medicine uses the patient's own stem cells to cure them.
Why did the central govt unlawfully release two genome edited rice varieties in India?
New gene-editing therapy shows early success in fighting advanced GI cancers: Minneapolis Monday, May 5, 2025, 17:00 Hrs [IST] Researchers at the University of Minnesota have comp ...
Shares of CRISPR Therapeutics (NASDAQ:CRSP) can’t seem to catch a break, now down close to 8% year to date and more than 80% ...
The CRISPR/Cas9 gene-editing technique has shown promise in fighting advanced colorectal cancer, according to results of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results